CDMOPライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (1 1月 1970 @ 09:00):

Stats
本日の出来高	12 466.00
平均出来高	11 339.00
時価総額	0.00
EPS	$0.0271 ( 2022-01-30 )
Last Dividend	$0.656 ( 2021-03-12 )
Next Dividend	$0 ( N/A )
P/E	-6 265.00
ATR14	$0 (0.00%)

Avid Bioservices, Inc. 相関

10 最も正の相関
RCON	0.899
ARHS	0.896
UBFO	0.893
SRAX	0.878
FSBW	0.876
BCML	0.876
CGBD	0.874
CVLY	0.872
KBWB	0.87
EWBC	0.87

10 最も負の相関
CNST	-0.888
ANGI	-0.883
EPZM	-0.877
DDOG	-0.872
LFVN	-0.861
LASR	-0.861
IOVA	-0.855
FLGT	-0.854
DMRC	-0.852
ANIP	-0.851

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Avid Bioservices, Inc. 財務諸表

Annual	2023
収益:	$149.27M
総利益:	$31.48M (21.09 %)
EPS:	$0.00900

FY	2023
収益:	$149.27M
総利益:	$31.48M (21.09 %)
EPS:	$0.00900

FY	2022
収益:	$119.60M
総利益:	$36.65M (30.64 %)
EPS:	$2.08

FY	2021
収益:	$95.87M
総利益:	$29.31M (30.57 %)
EPS:	$0.198

Financial Reports:

No articles found.

Avid Bioservices, Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Avid Bioservices, Inc. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0.0723 - No dividend growth expected in the near future

Information

First Dividend	$0.299	2014-03-19
Last Dividend	$0.656	2021-03-12
Next Dividend	$0	N/A
Payout Date	2021-04-01
Next Payout Date	N/A
# dividends	29	--
Total Paid Out	$18.67	--
Avg. Dividend % Per Year	1.06%	--
Score	2.21	--
Div. Sustainability Score	0
Div.Growth Potential Score	0.0723
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-28)

$0 Estimate 0.00 %

Dividend Stability

0.16 Bad

Dividend Score

2.21

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$2.62	14.70%
2019	$2.62	12.90%
2020	$2.62	11.10%
2021	$0.656	2.40%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.131	1.500	-2.62	-3.93	[0 - 0.5]
returnOnAssetsTTM	-0.0394	1.200	-1.312	-1.574	[0 - 0.3]
returnOnEquityTTM	-0.0963	1.500	-2.18	-3.27	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.465	0.800	-2.68	-2.14	[1 - 3]
quickRatioTTM	0.297	0.800	-2.96	-2.37	[0.8 - 2.5]
cashRatioTTM	0.138	1.500	-0.346	-0.519	[0.2 - 2]
debtRatioTTM	0.431	-1.500	2.81	-4.22	[0 - 0.6]
interestCoverageTTM	-10.85	1.000	-5.13	-5.13	[3 - 30]
operatingCashFlowPerShareTTM	0.194	2.00	9.94	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.608	2.00	-0.304	-0.608	[0 - 20]
debtEquityRatioTTM	1.090	-1.500	5.64	-8.46	[0 - 2.5]
grossProfitMarginTTM	0.0747	1.000	-2.09	-2.09	[0.2 - 0.8]
operatingProfitMarginTTM	-0.132	1.000	-4.64	-4.64	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0627	1.000	-0.763	-0.763	[0.2 - 2]
assetTurnoverTTM	0.300	0.800	-1.331	-1.065	[0.5 - 2]
Total Score				-0.942

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-25.98	1.000	-2.72	0	[1 - 100]
returnOnEquityTTM	-0.0963	2.50	-1.402	-3.27	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.608	2.00	-0.203	-0.608	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.194	2.00	9.94	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.261	1.500	-1.594	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0900	1.000	-0.250	0	[0.1 - 0.5]
Total Score				0.0723

Avid Bioservices, Inc.

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.